CYP2C19(⁎)2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls

Clopidogrel is an antiplatelet drug especially used in patients undergoing percutaneous coronary interventions (PCI). Polymorphisms within CYP2C19 can result in important interindividual variations regarding therapeutic efficacy. Therefore, we aimed to evaluate the impact of the CYP2C19(⁎)2 variant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruedlinger, Jenny, Prado, Yalena, Zambrano, Tomás, Saavedra, Nicolás, Bobadilla, Braulio, Potthoff, Marcelo, Pérez, Luis, Lanas, Fernando, Salazar, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530410/
https://www.ncbi.nlm.nih.gov/pubmed/28785581
http://dx.doi.org/10.1155/2017/5783719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530410/
https://www.ncbi.nlm.nih.gov/pubmed/28785581
http://dx.doi.org/10.1155/2017/5783719

Ejemplares similares